PVH
PPBT

Psagot Value Holdings’s Purple Biotech PPBT Stock Holding History

Psagot Value Holdings’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-17
Closed -$53K – 327
2017
Q2 		$53K Buy
+17
New +$61.9K ﹤0.01% 262
2017
Q1 		– Hold
0
– – – 326

Other funds holding PPBT

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Psagot Value Holdings's PPBT Position: Q3 2017 in Review

Psagot Value Holdings sold out of Purple Biotech (PPBT) in Q3 2017, closing a stake of 17 shares — an estimated $53K sold.

Psagot Value Holdings first reported a position in PPBT in Q2 2017 and held it in 1 quarter. The position peaked at $53K in Q2 2017. 5 funds tracked by Wall St. Rank hold PPBT as of Q3 2017.

  • Psagot Value Holdings reported no remaining Purple Biotech position as of Q3 2017 after selling out during the quarter.
  • Psagot Value Holdings sold 17 Purple Biotech shares in Q3 2017, an estimated $53K.
  • Psagot Value Holdings first reported a position in Purple Biotech in Q2 2017 and held it in 1 quarter.
  • Psagot Value Holdings's Purple Biotech position peaked at $53K in Q2 2017.
  • 5 funds tracked by Wall St. Rank held Purple Biotech as of Q3 2017.

Based on Psagot Value Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.